because type 2 has been identified as a cause of meningitis in man, particularly in men whose employment brings them into association with pigs (4) .
S. suis constitutes a subgroup in Lancefield's serological group D (1) . In this subgroup, two serological types, types 1 and 2, are distinguishable by the immunological specificity of a component thought to be a capsular polysaccharide (2) . In bactericidal tests, well capsulated strains grow readily in heparinized porcine and human blood . Such growth is inhibited by phagocytosis in the presence of typespecific antibody directed against the capsule (5) . It was, therefore, of interest to determine whether vaccination with capsular polysaccharide would elicit the production of type-specific antibodies in pigs. If this were so, such vaccination might protect against infection with homologous streptococci .
In this report we describe the extraction and purification of capsular polysaccharides from S. suis types 1 and 2 . We also present the results of a chemical and serological examination of these substances . A later paper will describe an investigation into the immunogenicity of type 2 polysaccharide in pigs .
Materials and Methods
Streptococcal Strains. Strains A228 and D928 belong to S. suis type 1 and were isolated from piglets with meningitis. Strain D930 belongs to S. suis type 2 and has been previously described (6) .
Streptococcal Antisera . Hyperimmune rabbit antisera were prepared with formalized vaccines by a method previously described (7) . Serum R800 was raised against strain A228 (type 1), serum R5037 against strain D930 (type 2), and serum R1647 against strain D76 (Streptococcus faecalis) .
Precipitin Tests. These were carried out using the capillary technique (8) . Analytical Methods . The protein content of the purified types 1 and 2 polysaccharides was determined by amino acid analyses . Polysaccharide (1 mg) was hydrolyzed in 4 N methane sulfonic acid (9) and the analysis was performed on a Durrum D-500 automatic amino acid analyzer using a one-column system (Durrum Instrument Corp ., Sunnyvale, Calif.) . Sugar analyses were performed by gas-liquid chromatography as described by Clamp et al . (10) . Polysaccharide (0 .1 mg) was hydrolyzed in 1 .5 N methanolic HCI at 80°C overnight, and the monosaccharides were analyzed as the trimethylsilyl ethers on a Varian model 3700 gas-liquid
Results
Isolation of Capsular Polysaccharides from S. Suis Types 1 and 2. S. suis was found to be susceptible to the lytic action of lysozyme which resulted in the release of capsular polysaccharide from both types 1 and 2. A 75-80% lysis ofthe cells was observed after 6-8-h incubation with lysozyme at 37°C. We describe in this paper the procedure followed in a typical experiment for the extraction of capsular polysaccharide from type 2 . The same procedure was used for the isolation of type 1 capsular polysaccharide.
S. suis type 2 (strain D930) was grown for 18 h at 37°C in 5 liters of Todd-Hewitt broth . The cocci were harvested by centrifugation, washed once in saline, and resuspended in 100 ml glycine buffer (0.1 M, pH 9.2) containing 10 mg crystalline, salt-free egg-white lysozyme (Worthington Biochemical Corp ., Freehold, N. J.) . Sodium azide in a final concentration of 0.02% was added to inhibit the growth of contaminants. The streptococcal suspension was then incubated for 6-8 h at 37°C with continuous mixing . During this time most ofthe capsular material, together with nucleic acid and other streptococcal components, was released into the supernatant fluid. After incubation of the lysozyme digest, the residual streptococcal debris was separated by centrifugation . From the supernatant fluid, nucleic acid was then removed by precipitation with ethanol (25% vol/vol) and CaC12 (0.1 M). Finally the capsular polysaccharide was precipitated from solution by increasing the ethanol concentration to 80% vol/vol . The precipitate was dissolved in 20-30 ml H2O and lyophilized after dialysis against H2O .
The dry polysaccharide was dissolved in 1/30 M phosphate buffer pH 8.0 and purified further by column chromatography on Sepharose 6B (Pharmacia Fine Chemicals, Div. of Pharmacia Inc ., Piscataway, N. J.) and eluted with the same buffer . Phenol sulfuric acid assay (12) and capillary precipitin tests with appropriate rabbit antisera were used to identify the capsule polysaccharides and the group D teichoic acid ( Fig. 1 and 2 ). It can be seen that the polysaccharide passed through the column unimpeded and was thereby separated from other streptococcal components including the Group D glycerol teichoic acid. The eluted capsular polysaccharide was dialyzed exhaustively against distilled water and then lyophilized . The final yield was 180 mg of type 2 polysaccharide from 5 liters of culture . For type 1 (strain D928), the yield was 60 mg polysaccharide from 5 liters of culture.
Characterization of Types 1 and 2 Capsular Polysaccharides. The purity of the isolated types 1 and 2 capsular polysaccharides was indicated by chemical and serological analyses . Type 1 polysaccharide was found to contain <0.1% of nucleic acid by 260 nm absorption and 0.3% of amino acids ; type 2 also had <0.1% of nucleic acid and 0.49% of amino acids . Type 1 polysaccharide is composed of five sugars : galactose, glucose, N-acetyl glucosamine, N-acetyl galactosamine, and sialic acid in a molar ratio of 2.42 :1 .00 :1 .00 :1 .13 :1 .39 (Table I) . Type 2 polysaccharide was found to differ only in one sugar: rhamnose substitutes for N-acetyl galactosamine which is absent in type 2. The type 2 polysaccharide contains rhamnose, galactose, glucose, N-acetyl glucosamine, and sialic acid in a molar ratio of 1 .07:3 .17 :1 .00 :0.94:1 .00 (Table I) Table II shows the reactivity ofthe purified capsular polysaccharides with streptococcal antisera of homologous and heterologous type. Tested with hyperimmune rabbit antisera raised against S. suis type 1 (serum R800) and type 2 (serum W5037), the polysaccharides in a concentration of 0.01 mg/ml showed immediate precipitation when mixed with antisera of homologous type. In concentrations up to 1 .0 mg/ml, neither polysaccharide showed any reaction with serum of heterologous type or with group D antiserum (R1647) raised against strain D76 (S. faecalis) .
Discussion
Our examination of the supernatant fluid from lysozyme digests of S. suis suggests that the two main components released by lysis of the streptococci are nucleic acid and capsular polysaccharide. We have also detected in digest fluids glycerol teichoic acid, the group D antigen, although much of this component remained with the insoluble streptococcal debris from which it could be extracted by aqueous phenol . So far, we have found in the digest supernates of capsulated strains no counterpart for the cell-wall carbohydrates that contribute to the structure of most hemolytic streptococci. The capsular polysaccharides of S. suis are readily distinguishable from typical streptococcal cell-wall carbohydrates by their high molecular weight and lability in hot acid. The behavior of these capsular polysaccharides on Sepharose columns suggests molecular weights of at least 100,000 . The loss of serological activity that occurs when the type 2 polysaccharide is heated in HCl to 100°C at pH 2 is in striking contrast to the resistance shown by typical wall carbohydrates to such treatment (2, 3) . Our failure to detect wall carbohydrate by serological tests may result from lack of a suitable antiserum . We have detected in type 1 digests a small amount of rhamnose which, because it is not part of the type 1 capsule, may have originated in a cell-wall carbohydrate . This possibility is under investigation .
It is of interest to compare the capsular type-specific polysaccharides of S. suis, the causal agent in porcine neonatal meningitis, with the type polysaccharides of group B streptococci responsible for human neonatal meningitis. In S. suis, the polysaccharides are readily detached from the cocci by digestion with lysozyme . Group B 
